A breakthrough in the fight against Alzheimer's was made by researchers at the University of Pittsburgh, where a test was ...

A team of researchers from the Keck School of Medicine of USC has unlocked the details of a cellular pathway that triggers cellular inflammation and aging and is linked to Alzheimer's disease, ...

Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...

A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau.

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

CHARLOTTESVILLE, Va. (WVIR) -A promising new study could bring us closer to finding better treatments for Alzheimer’s disease. One expert and her team are studying how tiny changes in brain ...

First patients with memory problems join ‘revolutionary’ trial by Oxford and Cambridge universities which could lead to ‘Holy ...

A new platform for studying neuroinflammatory diseases, utilizing advanced 3D bioprinting technology has been developed.

Scientists have discovered a potential new drug that could help people with Alzheimer’s disease by improving memory and ...

A research team has discovered that the two key pathological hallmarks of Alzheimer's -- tau protein and beta-amyloid -- affect brain circuits in distinct yet synergistic ways, particularly those ...

For years, scientists have focused on amyloid beta buildup as the main culprit in Alzheimer’s disease, but a new study suggests the real problem might lie in a stalled protein-cutting process in the ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...